Xponance’s Cano Health, Inc. CANO Stock Holding History

Xponance’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-134	Closed	-$3.4K	–	1299
2023 Q3	$3.4K	Hold	134	–	–	﹤0.01%	1242
2023 Q2	$18.6K	Buy	+134	New	+$17.2K	﹤0.01%	1253

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Xponance's CANO Position: Q4 2023 in Review

Xponance sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 134 shares — an estimated $3.4K sold.

Xponance first reported a position in CANO in Q2 2023 and held it in 2 quarters. The position peaked at $18.6K in Q2 2023. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

Xponance reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
Xponance sold 134 Cano Health, Inc. shares in Q4 2023, an estimated $3.4K.
Xponance first reported a position in Cano Health, Inc. in Q2 2023 and held it in 2 quarters.
Xponance's Cano Health, Inc. position peaked at $18.6K in Q2 2023.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Xponance's 13F filing for Q4 2023, filed 31 Jan 2024.